ATE298256T1 - Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung - Google Patents

Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung

Info

Publication number: ATE298256T1
Authority: AT; Austria
Prior art keywords: hyaluronic acid; microspheres; utility; properties; tissues
Prior art date: 2000-07-31

Application number

AT01959403T

Other languages

English (en)

Inventor

Ronald K Yamamoto

Stanley R Conston

Original Assignee

Iscience Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-31

Filing date

2001-07-31

Publication date

2005-07-15

2001-07-31 Application filed by Iscience Corp filed Critical Iscience Corp

2005-07-15 Application granted granted Critical

2005-07-15 Publication of ATE298256T1 publication Critical patent/ATE298256T1/de

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 4
229920002674 hyaluronan Polymers 0.000 title abstract 4
229960003160 hyaluronic acid Drugs 0.000 title abstract 4
239000012620 biological material Substances 0.000 title 1
239000011859 microparticle Substances 0.000 title 1
239000004005 microsphere Substances 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 4
238000009472 formulation Methods 0.000 abstract 3
230000004071 biological effect Effects 0.000 abstract 2
230000003510 anti-fibrotic effect Effects 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Oral & Maxillofacial Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Ophthalmology & Optometry (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01959403T 2000-07-31 2001-07-31 Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung ATE298256T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62900000A	2000-07-31	2000-07-31
PCT/US2001/024149 WO2002009787A1 (en)	2000-07-31	2001-07-31	Microparticulate biomaterial composition for medical use

Publications (1)

Publication Number	Publication Date
ATE298256T1 true ATE298256T1 (de)	2005-07-15

Family

ID=24521177

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01959403T ATE298256T1 (de)	2000-07-31	2001-07-31	Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung

Country Status (8)

Country	Link
EP (1)	EP1305057B1 (de)
JP (1)	JP2004505065A (de)
AT (1)	ATE298256T1 (de)
DE (1)	DE60111637T2 (de)
DK (1)	DK1305057T3 (de)
ES (1)	ES2244641T3 (de)
PT (1)	PT1305057E (de)
WO (1)	WO2002009787A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9498457B2 (en)	2004-04-30	2016-11-22	Allergan, Inc.	Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7993634B2 (en)	2004-04-30	2011-08-09	Allergan, Inc.	Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US7799336B2 (en)	2004-04-30	2010-09-21	Allergan, Inc.	Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8722097B2 (en)	2004-04-30	2014-05-13	Allergan, Inc.	Oil-in-water method for making polymeric implants containing a hypotensive lipid
SE0401182D0 (sv) *	2004-05-05	2004-05-05	Q Med Ab	Novel use of a viscoelastic composition
JP5313497B2 (ja) *	2004-05-27	2013-10-09	ノボザイムスバイオファーマデーコーアクティーゼルスカブ	乾燥および凝集されたヒアルロン酸生成物
US7956180B2 (en)	2004-05-27	2011-06-07	Novozymes A/S	Dried and agglomerated hyaluronic acid product
US8969415B2 (en)	2006-12-01	2015-03-03	Allergan, Inc.	Intraocular drug delivery systems
JP5526033B2 (ja) *	2007-11-14	2014-06-18	ザユニバーシティオブクィーンズランド	微粒子製造装置および微粒子製造方法
ITFI20130074A1 (it) *	2013-04-03	2014-10-04	Ambrosone Orazio	Soluzione acquosa di contrasto per rendere visibile mediante metodica fotografica il canale di schlemm e le vie di deflusso dell¿umore acqueo e metodo diagnostico che utilizza detta soluzione.
JP7216006B2 (ja)	2017-03-22	2023-01-31	ジェネンテック，インコーポレイテッド	ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法
CN114796619B (zh) *	2022-04-14	2023-03-14	珠海麦得发生物科技股份有限公司	可注射透明质酸微球及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2733426B1 (fr) *	1995-04-25	1997-07-18	Debacker Yves	Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US5752974A (en) *	1995-12-18	1998-05-19	Collagen Corporation	Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
FR2759576B1 (fr) *	1997-02-17	1999-08-06	Corneal Ind	Implant de sclero-keratectomie pre-descemetique
AU9313298A (en) *	1997-09-04	1999-03-22	Point Biomedical Corporation	Injectable tissue reconstruction material
IT1302534B1 (it) *	1998-12-21	2000-09-05	Fidia Advanced Biopolymers Srl	Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per

2001
- 2001-07-31 AT AT01959403T patent/ATE298256T1/de not_active IP Right Cessation
- 2001-07-31 PT PT01959403T patent/PT1305057E/pt unknown
- 2001-07-31 ES ES01959403T patent/ES2244641T3/es not_active Expired - Lifetime
- 2001-07-31 WO PCT/US2001/024149 patent/WO2002009787A1/en not_active Ceased
- 2001-07-31 EP EP01959403A patent/EP1305057B1/de not_active Expired - Lifetime
- 2001-07-31 DK DK01959403T patent/DK1305057T3/da active
- 2001-07-31 DE DE60111637T patent/DE60111637T2/de not_active Expired - Lifetime
- 2001-07-31 JP JP2002515338A patent/JP2004505065A/ja active Pending

Also Published As

Publication number	Publication date
EP1305057B1 (de)	2005-06-22
EP1305057A1 (de)	2003-05-02
WO2002009787A1 (en)	2002-02-07
PT1305057E (pt)	2005-11-30
DE60111637T2 (de)	2006-05-11
DK1305057T3 (da)	2005-10-24
ES2244641T3 (es)	2005-12-16
JP2004505065A (ja)	2004-02-19
DE60111637D1 (de)	2005-07-28

Legal Events

Date

Code

Title

Description

2006-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1305057

Country of ref document: EP

2010-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
US9468779B2 (en)	2016-10-18	Viscoelastic gel for dermatological use
KR102277655B1 (ko)	2021-07-15	분말 형태로 첨가되는 리도카인 및 알칼리 제제를 포함하며 히알루론산을 기본 성분으로 하고 열에 의해 살균된, 주입가능한 하이드로겔의 수득 방법
GEP20022804B (en)	2002-09-25	Erythropoietin Derivatives
ATE260651T1 (de)	2004-03-15	Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
ATE267798T1 (de)	2004-06-15	Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
BR0008590A (pt)	2001-10-30	Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ATE424848T1 (de)	2009-03-15	Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
SV2002000245A (es)	2002-01-15	Oxazolidinonas substituidas y su uso ref. lea 34122-sv
IS2114B (is)	2006-06-15	Kínasólínafleiður til að meðhöndla æxli
DE60111637D1 (de)	2005-07-28	Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
McKim et al.	2008	Dimethyl sulfoxide USP, PhEur in approved pharmaceutical products and medical devices
US20130004546A1 (en)	2013-01-03	Hydrogel of microspheres
WO2001038303A3 (fr)	2002-01-17	Analogues de la vitamine d
DE602005021770D1 (de)	2010-07-22	Indol-1-yl-essigsäurederivate
WO2017131130A1 (ja)	2017-08-03	コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
CA2455776C (en)	2012-08-28	Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
ATE424192T1 (de)	2009-03-15	Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
FR2744452B1 (fr)	1998-03-06	Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
JP2017043594A (ja)	2017-03-02	育毛組成物
Gencoglu et al.	2010	Comparision of biocompatibility and cytotoxicity of two new root canal sealers
DE69736985D1 (de)	2007-01-04	Biologisch aktive zusammensetzung
RU2204386C2 (ru)	2003-05-20	Композиция для новообразования коллагена
JP2018193329A (ja)	2018-12-06	トランスグルタミナーゼ発現促進剤
CN105535025A (zh)	2016-05-04	嫩肤美白营养液及嫩肤美白组合物
KR102540969B1 (ko)	2023-06-09	소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물